S&P also assigned an “A+” long-term rating to PHS’ $100.5 million of series 2016A revenue bonds.
“The rating action reflects our view of PHS’ solid financial performance in fiscal 2015 and through the first three quarters of 2016, supporting a good balance sheet with continued growth in unrestricted reserves,” said S&P credit analyst Allison Bretz.
The outlook is stable, reflecting S&P’s opinion of PHS’ stable market position, year-over-year net patient revenue growth and adequate balance sheet metrics.
More articles on healthcare finance:
How CHS, Tenet, UHS, LifePoint and HCA fared in Q1
6 healthcare CFOs in the headlines
Gundersen Health System CEO, CFO: Health Affairs study on nonprofit hospitals ‘simply not true’
